1. Academic Validation
  2. Selenization of Small Molecule Drugs: A New Player on the Board

Selenization of Small Molecule Drugs: A New Player on the Board

  • J Med Chem. 2024 May 23;67(10):7759-7787. doi: 10.1021/acs.jmedchem.3c02426.
Cristina Morán-Serradilla 1 Daniel Plano 1 Carmen Sanmartín 1 Arun K Sharma 2 3
Affiliations

Affiliations

  • 1 Department of Pharmaceutical Sciences, University of Navarra, Irunlarrea 1, Pamplona E-31008, Spain.
  • 2 Department of Pharmacology, Penn State College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, United States.
  • 3 Penn State Cancer Institute, 400 University Drive,Hershey, Pennsylvania 17033, United States.
Abstract

There is an urgent need to develop safer and more effective modalities for the treatment of a wide range of pathologies due to the increasing rates of drug resistance, undesired side effects, poor clinical outcomes, etc. Throughout the years, selenium (Se) has attracted a great deal of attention due to its important role in human health. Besides, a growing body of work has unveiled that the inclusion of Se motifs into a great number of molecules is a promising strategy for obtaining novel therapeutic agents. In the current Perspective, we have gathered the most recent literature related to the incorporation of different Se moieties into the scaffolds of a wide range of known drugs and their feasible pharmaceutical applications. In addition, we highlight different representative examples as well as provide our perspective on Se drugs and the possible future directions, promises, opportunities, and challenges of this ground-breaking area of research.

Figures